Related Experiment Video

Updated: Oct 3, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor

Evdokia A Pasheva1, Iva Ugrinova, Nadejda C Spassovska

  • 1Institute of Molecular Biology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.

The International Journal of Biochemistry & Cell Biology
|December 6, 2001
PubMed

Insights

High mobility group (HMG) protein 1 binds to cis-platin DNA adducts, potentially blocking repair and contributing to antitumor activity. This binding affinity correlates with drug efficacy, offering a new screening method.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Discovery

Background:

  • Cis-platin's antitumor activity involves DNA interaction and processing by DNA damage recognition proteins.
  • High mobility group (HMG) proteins 1 and 2 are hypothesized to mediate cis-platin's effects.
  • A proposed mechanism involves HMG1 binding to DNA adducts, inhibiting DNA repair.

Purpose of the Study:

  • To evaluate the mechanism by which HMG1 might mediate cis-platin's antitumor effects.
  • To determine the binding affinity of HMG1 to DNA adducts induced by various cis-platinum complexes.
  • To assess the correlation between HMG1 binding affinity and the antitumor activity of platinum compounds.

Main Methods:

  • Treated DNA with several cis-platinum complexes exhibiting known antitumor activity.
  • Determined the affinity of HMG1 to the DNA adducts induced by each drug.
  • Utilized gel mobility shift assays to quantify dissociation constants for HMG1-platinated DNA complexes.

Main Results:

  • A direct correlation was observed between the antitumor activity of tested platinum compounds and HMG1 binding affinity to their respective drug-DNA adducts.
  • Higher binding affinity of HMG1 to DNA adducts was associated with greater antitumor efficacy.
  • These findings support the role of HMG1 in shielding damaged DNA from repair.

Conclusions:

  • HMG1 likely contributes to the cytotoxicity of cis-platin by preventing DNA repair, thus enhancing the drug's antitumor effect.
  • The study provides evidence supporting HMG1's role in cis-platin's mechanism of action.
  • The determined binding affinity offers a rapid screening method for identifying new platinum compounds with potential antitumor activity.

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium: